Trastuzumab (Herceptin-class) dose

Hospital buy vs billed (illustrative WAC/GPO/340B blend) Specialty / biosimilar / 340B

What the hospital pays (acquisition)$4,200

Cash$6,800

Medicaid$3,800

Medicare$4,500

Insured$9,200

Medicaid

$3,800

Medicare

$4,500

Cash

$6,800

Insured

$9,200

Insured path is $2,400 (35%) above cash. Hospital buy $4,200 vs insured $9,200.

Payers: modeled — see evidence.